Friedreich Ataxia: all 111 studies
Page 2 of 2. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.
- Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's AtaxiaCompletedNCT01016366Phase 2
- A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's AtaxiaCompletedNCT00897221Phase 2
- Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of ConceptCompletedNCT00811681Phase 3
- Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's AtaxiaTerminatedNCT00803868Phase 2/3
- Efficacy of Epoetin Alfa in Patients With Friedreich's AtaxiaCompletedNCT00631202Phase 2
- A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's AtaxiaCompletedNCT00530127Phase 1/2
- Idebenone to Treat Friedreich's AtaxiaCompletedNCT00229632Phase 2
- Iron-Chelating Therapy and Friedreich AtaxiaCompletedNCT00224640Phase 1/2
- Phase 1 Trial of Idebenone to Treat Patients With Friedreich's AtaxiaCompletedNCT00078481Phase 1
- Transitional Life Events in Patients With Friedreich's Ataxia: Implications for Genetic CounselingCompletedNCT00056186
- Safety Study of Idebenone to Treat Friedreich's AtaxiaCompletedNCT00015808Phase 1